For Company Research, enter symbol or keyword and choose type of research:    Symbol Search
American Renal Associates
(NYSE: ARA) Add to Portfolio
$7.05
+0.04 (+0.57%)
as of Jun 21, 2019

Last 7.05
Change +0.04 (+0.57%)
Open 6.96
Prev. Close 7.01
Today's Range
6.72 7.11
52wk Range
5.48 23.99
Volume 297,800
Avg Volume 216,695
Sector SIC-8090 Services-Misc Health & Allied Services, NEC

Recent Headlines
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses in excess of $100,000 that they have only until May 28, 2019 to file (full story)
ARA: 7.05 (+0.04)
Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of American Renal Associates Holdings, Inc., Apple Inc., Intersect ENT, Inc., and Momo Inc. Stockholders have (full story)
ARA: 7.05 (+0.04), MOMO: 33.72 (-0.09), AAPL: 198.91 (+0.13), XENT: 23.15 (-0.47)
Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming May 28, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of American Renal Associates Holdings, Inc. ("American Renal" or the " (full story)
ARA: 7.05 (+0.04)
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links (full story)
ARA: 7.05 (+0.04), MBT: 9.21 (+0.09), HCSG: 30.30 (-2.23)
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: (full story)
ARA: 7.05 (+0.04), AAPL: 198.91 (+0.13), ORN: 2.29 (unch)
 
Performance Comparison
Name Today 3-Month 1-Year
ARA +0.57% +5.38% -57.12%
Growth Rates
YTD -38.80%
1-Year -57.48%
3-Year -74.92%
© 2019 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. SEC Filings provided by Edgar Online. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.